> top > docs > PMC:7377212 > spans > 20423-21264 > annotations

PMC:7377212 / 20423-21264 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T163 20-36 CHEBI:35705;CHEBI:35705 denotes immunomodulatory
T164 37-42 CHEBI:23888;CHEBI:23888 denotes drugs
T165 73-88 PR:000001137 denotes interleukin-1Ra
T166 91-102 DG_35 denotes tocilizumab
T167 109-122 PR:000001393 denotes interleukin-6
T168 141-151 CHEBI:35222;CHEBI:35222 denotes inhibitors
T169 185-193 SP_7 denotes COVID-19
T170 495-504 UBERON:0002048 denotes pulmonary
T171 623-631 SP_7 denotes COVID-19
T172 632-641 UBERON:0002048 denotes pulmonary
T173 724-735 UBERON:0001004 denotes respiratory
T174 769-777 SP_7 denotes COVID-19
T69247 35-50 CHEBI:35705;CHEBI:35705 denotes y drugs such as
T20303 51-56 CHEBI:23888;CHEBI:23888 denotes anaki
T81754 87-93 PR:000001137 denotes a), to
T16643 96-107 DG_35 denotes izumab (ant
T55627 114-117 PR:000001393 denotes leu
T41646 142-152 CHEBI:35222;CHEBI:35222 denotes nhibitors,
T67111 186-193 SP_7 denotes OVID-19
T31029 495-504 UBERON:0002048 denotes pulmonary
T56928 623-630 SP_7 denotes COVID-1
T40668 631-640 UBERON:0002048 denotes pulmonar
T57506 723-734 UBERON:0001004 denotes respirator
T68575 768-776 SP_7 denotes COVID-1

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T51 73-84 Body_part denotes interleukin http://purl.org/sig/ont/fma/fma86578
T52 109-122 Body_part denotes interleukin-6 http://purl.org/sig/ont/fma/fma264829

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
601 73-88 Gene denotes interleukin-1Ra Gene:3557
603 215-223 Species denotes patients Tax:9606
604 293-301 Species denotes patients Tax:9606
605 580-588 Species denotes patients Tax:9606
606 695-703 Species denotes patients Tax:9606
607 268-279 Species denotes Aspergillus Tax:746128
608 91-102 Chemical denotes tocilizumab MESH:C502936
609 185-193 Disease denotes COVID-19 MESH:C000657245
611 548-564 Disease denotes cavitary disease MESH:C566924
612 623-650 Disease denotes COVID-19 pulmonary fibrosis MESH:C000657245
613 724-744 Disease denotes respiratory problems MESH:D012818
614 769-777 Disease denotes COVID-19 MESH:C000657245
615 778-787 Disease denotes infection MESH:D007239

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T211 185-193 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T212 227-231 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T213 505-518 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T214 623-631 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T215 632-650 Disease denotes pulmonary fibrosis http://purl.obolibrary.org/obo/MONDO_0002771
T216 769-777 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T217 778-787 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T177 109-122 http://purl.obolibrary.org/obo/PR_000001393 denotes interleukin-6
T178 538-539 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T179 568-569 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T303 37-42 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T304 91-102 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T305 141-151 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T4 134-151 http://purl.obolibrary.org/obo/GO_0033673 denotes kinase inhibitors

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T105 233-456 Sentence denotes There is also an increased risk of Aspergillus exposure for patients who are treated in hospital wards or makeshift “hospital” facilities that do not meet ICU specifications for appropriate room ventilation and air changes.
T106 457-651 Sentence denotes It is also worth bearing in mind that pulmonary aspergillosis could develop into a chronic cavitary disease in a subset of patients, perhaps in those developing post-COVID-19 pulmonary fibrosis.
T107 652-841 Sentence denotes For these reasons, clinicians following up patients manifesting chronic respiratory problems following their primary COVID-19 infection should bear in mind longer term fungal complications.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T49 632-650 Phenotype denotes pulmonary fibrosis http://purl.obolibrary.org/obo/HP_0002206
T50 724-744 Phenotype denotes respiratory problems http://purl.obolibrary.org/obo/HP_0002795